Skip to content
Subscriber Only

How Michael Cohen Became a $1.2 Million Headache for Novartis

  • Drugmaker works to repair tarnished image after Cohen deal
  • Jimenez: ‘It was clear that he had oversold his abilities’
Bloomberg business news

Novartis General Counsel Out Over Cohen Contract

When Michael Cohen showed up at Novartis AG last year proposing to help the drugmaker navigate the Donald Trump administration, it sounded like a promising opportunity. Cohen had, after all, served as an attorney for Trump and had close ties to the new president.

It didn’t take long for Novartis to conclude Cohen was full of hot air. And soon -- but not soon enough -- the company realized he was also a hot potato.